NCT02144181View on ClinicalTrials.gov

Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

October 31, 2016

Conditions
Erythematotelangiectatic RosaceaRosacea
Interventions
DEVICE

Ulthera System Treatment

Focused ultrasound energy delivered below the surface of the skin

Trial Locations (5)

17036

All About Faces, Hummelstown

23462

Laser & Cosmetic Center, Virginia Beach

28405

Wilmington Dermatology Center, Wilmington

68144

Skin Specialists, PC, Omaha

V8R 6V4

Cosmedica Laser Centre, Victoria

All Listed Sponsors
lead

Ulthera, Inc

INDUSTRY

NCT02144181 - Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea | Biotech Hunter | Biotech Hunter